Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Covington
US Army
Fuji
Boehringer Ingelheim
Julphar
Deloitte
Cerilliant
McKesson

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021676

« Back to Dashboard

NDA 021676 describes YAZ, which is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from four suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the YAZ profile page.

The generic ingredient in YAZ is drospirenone; ethinyl estradiol. There are ten drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.
Summary for 021676
Tradename:YAZ
Applicant:Bayer Hlthcare
Ingredient:drospirenone; ethinyl estradiol
Patents:3
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021676
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
YAZ drospirenone; ethinyl estradiol TABLET;ORAL 021676 NDA AUTHORIZED GENERIC Teva Pharmaceuticals USA Inc 0093-5423 N 0093-5423-58
YAZ drospirenone; ethinyl estradiol TABLET;ORAL 021676 NDA AUTHORIZED GENERIC Teva Pharmaceuticals USA Inc 0093-5423 N 0093-5423-62

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength3MG;0.02MG
Approval Date:Mar 16, 2006TE:ABRLD:Yes
Patent:➤ Sign UpPatent Expiration:Aug 31, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Dec 20, 2021Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Dec 20, 2021Product Flag?Substance Flag?Delist Request?
Patented Use:PREVENTION OF PREGNANCY

Expired US Patents for NDA 021676

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare YAZ drospirenone; ethinyl estradiol TABLET;ORAL 021676-001 Mar 16, 2006 ➤ Sign Up ➤ Sign Up
Bayer Hlthcare YAZ drospirenone; ethinyl estradiol TABLET;ORAL 021676-001 Mar 16, 2006 ➤ Sign Up ➤ Sign Up
Bayer Hlthcare YAZ drospirenone; ethinyl estradiol TABLET;ORAL 021676-001 Mar 16, 2006 ➤ Sign Up ➤ Sign Up
Bayer Hlthcare YAZ drospirenone; ethinyl estradiol TABLET;ORAL 021676-001 Mar 16, 2006 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Merck
Federal Trade Commission
Accenture
Chinese Patent Office
Johnson and Johnson
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.